The Digital Clinical Trial: Global Imaginaries and Infrastructural Optimism
On the 6th of February, 2018, the Clinical Trials Transformation Initiative (CTTI), a private-public initiative between Duke University and the US FDA, celebrated its ten-year anniversary. In his keynote speech, Robert Califf, former director of the US FDA argued that the opportunity to connect previously disconnected data systems meant a digital revolution ‘blurring the lines between physical digital and biological spheres’ (Cusher 2018). In the last decade, the randomized control trial, biomedicine’s ‘dominant apparatus of truth making’ (Kaufman 2016:144) has faultered under the complexity of contemporary global monitoring and governance. Against this backdrop, visions for an “in silico” future of research conjure real-time computational global networks, data collection made possible using a myriad of digital technologies and infrastructures. In this presentation, I present some early stage research into contrasting visions of components of the global digital trial, from new softwares for ethics committees to the challenges for regulators faced with new kinds of data. Looking toward research yet to come, can ethnographic research in the space where technologies are designed and deployed ground the speculative nature of digital transformation?
Date: 30 May 2018, 11:00 (Wednesday, 6th week, Trinity 2018)
Venue: Big Data Institute (NDM), Old Road Campus OX3 7LF
Venue Details: Seminar room 0
Speaker: Rachel Douglas-Jones (Caroline Miles Scholar)
Organising department: Ethox Centre
Organisers: Christa Henrichs (Wellcome Centre for Ethics and Humanities), Jane Beinart (University of Oxford)
Hosts: Wellcome Centre for Ethics and Humanities (University of Oxford), The Ethox Centre
Part of: Ethox Centre Seminars
Booking required?: Required
Booking email:
Audience: Public
Editor: Christa Henrichs